Share >  
Share
Share on Tumblr

Finish Dosages

News »

   latest by relevance
USFDA approval of plant a shot in the arm for Ranbaxy
Nov 30, 2011 at 17:16 | Source: CNBC-TV18
In what could be the biggest boost for Ranbaxy in more than three years, sources suggest that the US FDA has given an approval for Ranbaxy's finished dosage plant in Mohali, reports Archana Shukla of CNBC-TV18.
Aanjaneya Lifecare says robust growth is on cards for FY12
May 27, 2011 at 12:05 | Source: CNBC-TV18
Aanjaneya Lifecare debuted on the National Stock Exchange today. Kannan K Vishwanath, VC and MD, Aanjaneya Lifecare talks to CNBC-TV18 about the latest happenings in his company and what the road ahead looked like.
Orchid Chem to sell generic injectable biz; stk gains 4%
Dec 16, 2009 at 09:57 | Source: Moneycontrol.com
Orchid Chemicals and Pharmaceuticals is going to sell generic injectable finished dosage from pharma business to Hospira for USD 400 million, reports CNBC-TV18. It touched a 52-week high of Rs 233.90. At 09:56 am, the share was quoting at Rs 230, up Rs 9.05, or 4.10% on the NSE.
Granules India's revenue to go up to Rs 450cr by year-end
Sep 25, 2009 at 16:36 | Source: Moneycontrol.com
Revenues of Granules India Ltd, which had signed a USD 50 million contact with an MNC last year, are expected to go up to Rs 450 crore expect by the end of this year, says its Chief Marketing Officer Harsha Thigurupati. "Most of this will be fueled by API but more so because of increased finished dosages sale," he adds.
Dr Reddys to exit small generic drug markets abroad
Mar 20, 2009 at 08:34 | Source: Business Line
Pharma major Dr Reddys Laboratories Ltd has decided to exit from the small distributor-driven markets in its global generics business. It would now focus more on key markets.
Aurobindo Pharma in licensing agreement with Pfizer; stk up
Mar 04, 2009 at 10:16 | Source: Moneycontrol.com
Aurobindo Pharma had touched an intraday high of Rs 164.70 and an intraday low of Rs 158.80. At 10:15 am, the share was quoting at Rs 164.30, up Rs 7.90, or 5.05% on the NSE. The company has entered into licensing agreement with Pfizer for supply of finished dosage products, reports CNBC-TV18. It was trading with volumes of 160,354 shares.

Videos »
USFDA approval of plant a shot in the arm for Ranbaxy
Aanjaneya Lifecare says robust growth is on cards for FY12
Granules India's revenue to go up to Rs 450cr by year-end
Orchid Chemicals, Ranbaxy ink product pact
Rupee appreciation would not hit badly: Granules
more »

Photos »

  /  
News across the web »
Indian pharma companies like Hetero, Alembic, Lupin, Dr Reddy s dominating US generic space
MUMBAI: India is playing a dominant role in the US generic pharma space, having cornered over half the certified dossiers filed globally for active pharmaceutical ingredients (API). Drug companies fr...
May 04, 2012 at 09:36 | Source: Economic Times
Granules' Q4 net jumps 85.7%
Hyderabad-based drug maker Granules India Limited has reported a 85.7 per cent jump in net profit to Rs 16.37 crore for the quarter ended March 2012, more than half of the full year's bottom line, as ...
Apr 25, 2012 at 11:41 | Source: Business Standard
Granules India Q4 net up 46%
Hyderabad, April 24: Granules India Ltd’s consolidated net profit increased 46 per cent to Rs 16.37 crore in the fourth quarter ended March 31, 2012 compared with Rs 8.82 crore in the year-ago ...
Apr 24, 2012 at 16:32 | Source: The Hindu BusinessLine
Don't shut door on cheap drugs
One industry that, arguably, did not feel the effects of the global slowdown, or inflationary pressures, was pharmaceuticals. Several forecasts and studies have projected a robust growth for the sect...
Apr 23, 2012 at 23:27 | Source: The Hindu BusinessLine
Ranbaxy gets nod to market RAN-Rosuvastatin tablets
Ranbaxy Pharmaceuticals Canada Inc. (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RPCI has received approval from Health Canada to manufacture and market RAN...
Mar 31, 2012 at 17:48 | Source: India Infoline
more »
Interact & exchange stock tips & market info »

excelajay

Platinum Member

57 Followers

Marg  

active pharma ingredients and finished dosage forms, an...

12.13 PM Dec 19th 2011

smartprofit
21

Gold Member

9 Followers

Sun Pharma  

operations at Rs 1895 crores, registering a growth of 42% over sa...

12.16 PM Dec 8th 2011

Nordic Erwin

Platinum Member

29 Followers

Granules India  

-inflammatory drug, is used to reduce pain, fever and inflammation. ...

12.30 PM Nov 10th 2011

Related News »
A scary dentist visit? Boy's parents claim sedation endangered son's well-being
A staffer for Zhu told them, "We can't be with our patients from start to finish of a sedation process," Rebekah ... that dentists must document the name and dosages of medications given, and if children receive different sedative drugs ...
May 27, 2012 at 07:11 | Source: Detroit Free Press
The honeybees are still dying
Perhaps chronic exposure to low doses of poisons disorients bees, or interrupts brood-production, or weakens them so that another pathogen—one that would under normal circumstances cause only limited mortality—can finish them off. In a recent review of ...
May 6, 2012 at 23:57 | Source: Boing Boing (blog)

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window